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Abstract
Radiation therapy (RT) is an effective strategy for the treatment of localized prostate cancer (PCa) as well as local
invasion. However, some locally advanced cancers develop radiation resistance and recur after therapy; therefore,
the development of radiation-sensitizing compounds is essential for treatment of these tumors. DOC-2/DAB2 in-
teractive protein (DAB2IP), which is a novel member of the Ras–GTPase activating protein family and a regulator of
phosphatidylinositol 3-kinase–Akt activity, is often downregulated in aggressive PCa. Our previous studies have
shown that loss of DAB2IP results in radioresistance in PCa cells primarily because of accelerated DNA double-strand
break (DSB) repair kinetics, robust G2/M checkpoint control, and evasion of apoptosis. A novel DNA-PKcs inhibitor
NU7441 can significantly enhance the effect of radiation in DAB2IP-deficient PCa cells. This enhanced radiation
sensitivity after NU7441 treatment is primarily due to delayed DNA DSB repair. More significantly, we found that
DAB2IP-deficient PCa cells show dramatic induction of autophagy after treatment with radiation and NU7441. How-
ever, restoring DAB2IP expression in PCa cells resulted in decreased autophagy-associated proteins, such as LC3B
and Beclin 1, as well as decreased phosphorylation of S6K andmammalian target of rapamycin (mTOR). Furthermore,
the presence of DAB2IP in PCa cells can lead to more apoptosis in response to combined treatment of NU7441 and
ionizing radiation. Taken together, NU7441 is a potent radiosensitizer in aggressive PCa cells and DAB2IP plays a crit-
ical role in enhancing PCa cell death after combined treatment with NU7441 and radiation.
Neoplasia (2012) 14, 1203–1212
Abbreviations: PCa, prostate cancer; DAB2IP, DOC-2/DAB2 interactive protein; mTOR, mammalian target of rapamycin; IR, ionizing radiation; RT, radiation therapy;
DSBs,double-strand breaks; 6-TG, 6-thioguanine; BRFS, biochemical recurrence-free survival; IHC, immunohistochemistry; AVOs, acidic vesicular organelles
Address all correspondence to: Debabrata Saha, PhD, Department of Radiation Oncology, Division of Molecular Radiation Biology, University of Texas Southwestern Medical
Center, 2201 Inwood Road, Dallas, TX 75390-9187. E-mail: debabrata.saha@utsouthwestern.edu
1This work was supported by the funding from Department of Defense Idea Award W81XWH-11-1-0270 (D.S.), Flight Attendant Medical Research Institute Award grant
(D.S.), and a Clinical Research Fellowship (V.T.) from the Doris Duke Charitable Foundation. Conflict of interest: None.
2This article refers to supplementary material, which is designated by Figure W1 and is available online at www.neoplasia.com.
Received 8 August 2012; Revised 10 October 2012; Accepted 12 October 2012
Copyright © 2012 Neoplasia Press, Inc. All rights reserved 1522-8002/12/$25.00
DOI 10.1593/neo.121310
www.neoplasia.com
Volume 14 Number 12 December 2012 pp. 1203–1212 1203
Introduction
Prostate cancer (PCa) is the most common type of non-skin cancer
and the second leading cause of cancer-related death in U.S. men
[1]. Radiation therapy (RT) provides excellent local control and in-
creased overall survival for PCa [2]. However, a significant proportion
of high-risk patients display radiation resistance and develop metastatic
disease in less than 5 years [3]. Elucidation of biomarkers and their
effects on mediating therapeutic resistance may allow physicians to
personalize care based on genotype. DOC-2/DAB2 interactive protein
(DAB2IP)/AIP1, a novel member of the RAS–GTPase activating
protein family, acts as a tumor suppressor but is often downregulated
in aggressive PCa [4]. Our previous work demonstrated that loss of
DAB2IP expression results in increased radioresistance in both PCa
cells and normal prostate epithelia [5,6]. Therefore, elucidating the
mechanism by which loss of DAB2IP induces radioresistance will
provide useful information in identifying new strategies to sensitize
DAB2IP-deficient PCa cells to RT.
DNA-PKcs, the catalytic subunit of DNA-dependent protein kinase
and member of the phosphatidylinositol 3-kinase (PI3K)–like fam-
ily, plays a dominant role in nonhomologous end joining (NHEJ)–
mediated DNA double-strand break (DSB) repair [7]. Furthermore,
DNA-PKcs may play a role in initiating DNA DSB–induced apoptosis
[8,9]. Upon recruitment to DSB sites, DNA-PKcs phosphorylates
downstream targets involved in DNA repair response and promotes
direct ligation of broken DNA ends. Accordingly, suppression of
DNA-PKcs leads to ineffective DSB repair and increases the cyto-
toxicity of ionizing radiation (IR) and other DSB-inducing agents [10].
On the basis of the important role of DNA-PKcs in NHEJ, inhibition of
DNA-PKcs is, therefore, an attractive approach to overcome the resistance
of RT. Our primary goal of this study is to develop strategies to overcome
radioresistance of DAB2IP-negative PCa and improve the efficacy of RT
in PCa using NU7441, a potent and specific inhibitor of DNA-PKcs.
Recent studies suggest that DNA-PKcs is involved in DNA damage–
induced autophagy. Specifically, inhibition of DNA-PKcs sensitized
malignant glioma cells to radiation-induced autophagic cell death [11].
However, autophagy, which normally results in degradation of dam-
aged or potentially dangerous proteins and organelles, may have a pro-
survival function, which protects cells from various forms of cellular
stress [12]. Several studies indicate that pharmacologic or genetic in-
hibition of autophagy can enhance cancer treatments by sensitizing
cancer cells to both radiation and chemotherapy [13]. On the basis of
these reports, we analyzed the levels of autophagy in NU7441-treated
DAB2IP-deficient and DAB2IP-proficient PCa cells to investigate
whether suppression of DNA-PKcs can confer to radiation-induced
autophagy in PCa cells. In this study, we show a novel function of
DAB2IP in suppressing IR-induced and DNA-PKcs–associated
autophagy and promoting apoptosis in PCa cells. Despite that NU7441
could significantly enhance the effect of RT in DAB2IP-negative
PCa, the combination of NU7441 and DAB2IP expression resulted
in greater RT efficacy due to autophagy inhibition.
Materials and Methods
Cell Culture and Irradiation
PCa cell lines C4-2 and PC3 were grown in T medium (Invitrogen,
Carlsbad, CA) with 5% FBS (HyClone, Hudson, NH) at 37°C with
5% CO2 in a humidified chamber. C4-2 neo (DAB2IP-negative) and
C4-2 D2 (DAB2IP-positive) were generated from C4-2 cells, and
PC3 Con (DAB2IP-positive) and PC3 KD (DAB2IP knockdown)
were generated from PC3 cells as described previously [5]. All cells
were irradiated in ambient air using a 137Cs source (Mark 1-68 irra-
diator; J.L. Shepherd & Associates, San Fernando, CA) at a dose rate
of 3.47 Gy/min at room temperature. NU7441 was purchased from
Tocris Bioscience (Ellisville, MO); NVP-BEZ225 was purchased from
SelleckBio (Houston, TX); rapamycin and RAD001 (Everolimus) were
purchased from LC Laboratories (Woburn, MA); LY294002 was pur-
chased from EMD Millipore (Billerica, MA).
Antibodies
Anti–phospho-histone γH2AX (Ser139) was obtained from EMD
Millipore. 53BP1, mammalian target of rapamycin (mTOR), phospho-
mTOR (pmTOR, S2448), phospho-S6 kinase (pS6K, T389), AKT,
phospho-AKT (pAKT, S473), LC3B, Beclin 1, and poly (ADP-ribose)
polymerase (PARP) antibodies were purchased from Cell Signaling
Technology (Danvers, MA). Anti-actin antibody was purchased from
Sigma-Aldrich (St Louis, MO). Fluorescent dye–conjugated secondary
antibodies were obtained from Invitrogen.
Clonogenic Survival Assay
Exponentially growing cells were trypsinized and counted using a
Coulter counter (Beckman Coulter, Fullerton, CA). Cells were diluted
serially to appropriate concentrations and plated into 60-mm dishes in
triplicates. After 3 hours of incubation, cells were treated with increas-
ing doses of IR (2, 4, 6, and 8 Gy) or NU7441 (1 μM) or NU7441 +
IR. After 10 to 14 days, cells were fixed and stained with 4% formal-
dehyde and 0.05% crystal violet in phosphate-buffered saline (PBS).
Colonies containing >50 cells were counted. Surviving fraction (SF)
was calculated as (mean colony counts)/[(cells inoculated) × (plating
efficiency)], in which plating efficiency was defined as (mean colony
counts)/(cells inoculated for unirradiated controls). The data are pre-
sented as the mean ± SD of at least three independent experiments.
The curve S = e−(αD + βD2) was fitted to the experimental data with a
least-squares fit algorithm using the program Sigma Plot 11.0 (Systat
Software, Inc, Chicago, IL).
The Detection of γH2AX and 53BP1 Foci
The 53BP1 and phosphorylation of H2AX (γH2AX) were used
as an indicator of DNA DSB. Cells were cultured for the indicated
times to repair DNA lesions after irradiation either alone or combined
with NU7441. The cells were fixed in 4% paraformaldehyde/PBS for
30 minutes, permeabilized in 0.5% Triton X-100/PBS for 15 minutes,
and blocked in 5% BSA for 30 minutes. The samples were incu-
bated with anti–phospho-histone γH2AX (Ser139; 1:2000) and 53BP1
(1:500) for 1 hour, washed in PBS for 10 minutes three times, and
incubated with Alexa Fluor 488–conjugated goat anti-rabbit and
rhodamine red–conjugated goat anti-mouse secondary antibodies
(1:1000) for 1 hour. The cells were washed for 10 minutes three times
and mounted using VECTASHIELD mounting medium with 4′,6-
diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame,
CA). The number of γH2AX and 53BP1 foci was examined using a
fluorescence microscope.
Cell Cycle Analysis
The treatment or control cells were harvested and fixed using 75%
ethanol either immediately or at the indicated time after radiation and
radiation + NU7441. The cells were resuspended in PBS containing
1 μg/ml RNase A (Sigma, St Louis, MO), incubated for 30 minutes
at 37°C, and stained with 100 μg/ml propidium iodide (Sigma)
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for 15 minutes at 4°C. The cell cycle distribution was analyzed us-
ing flow cytometry, and a minimum of 10,000 cells per sample
were counted.
Detection of Acidic Vesicular Organelles
Cells were grown in 60-mm dishes and allowed to attach overnight.
The cells were treated with radiation or radiation + NU7441 as indi-
cated and then were incubated with 1 μg/ml acridine orange (AO)/PBS
for 15 minutes, washed with PBS, and examined under LSM 510 laser
scanning confocal microscope (Zeiss) at ×63 magnification. Untreated
cells were also cultured for 3 days as a negative control. The samples
were collected for FACScan and analyzed using Flowjo 8.7.1 (Tree
Star, Inc, Ashland, OR) software to quantify cells that were positive
for acidic vesicular organelles (AVOs).
Retrospective Cohort Analysis
Patients with high-risk disease (stage T3a or greater, Gleason score >
7, or prostate-specific antigen > 20) treated with definitive RT between
2005 and 2011 at the University of Texas Southwestern Medical
Center were identified. Immunohistochemistry (IHC) analysis for
DAB2IP protein was performed on their biopsy specimens. DAB2IP
status was scored in the tumors by an expert genitourinary pathologist.
A loss of DAB2IP was determined by one or more biopsy cores with
decreased expression of the protein in the prostatic adenocarcinoma
compared to the surrounding normal prostate tissue. Biochemical
recurrence-free survival (BRFS) of patient cohorts with and without
DAB2IP loss was determined using the Phoenix definition. Log-rank
test was used to correlate BRFS with DAB2IP levels. Univariate analy-
sis of BRFS to pretreatment prostate-specific antigen, Gleason score,
stage, age, and DAB2IP status was performed.
Statistical Analysis
Data are presented as the means ± SD of at least three independent
experiments. The results were tested for significance using the unpaired
Student’s t test.
Results
NU7441 Sensitizes DAB2IP-deficient Cells to Irradiation
To test the effect of NU7441 on the radiosensitivity of DAB2IP-
positive and DAB2IP-negative PCa cells, we employed PC3 cell line
(DAB2IP-positive) and C4-2 cell line (DAB2IP-negative) and its
Figure 1. NU7441 increases the radiosensitivity in both DAB2IP-negative and DAB2IP-positive PCa cell lines. (A) The SF analysis of
C4-2 D2 and C4-2 neo cells after combined treatment with 1 μM NU7441 and IR as indicated. (B) SF analysis of DAB2IP-knockdown
PC3 cells (PC3-KD) and PC3 Con cells after treatment with 1 μMNU7441 and IR as indicated. (C) The survival curves of PC3 KD cells after
combination treatment with 0.5 to 5 μM NU7441 and irradiation at doses of 0 to 8 Gy. In all studies, results are expressed as the means
± SD from three independent experiments.
Neoplasia Vol. 14, No. 12, 2012 DAB2IP Regulates Autophagy in PCa Radiotherapy Yu et al. 1205
sublines [5]. As shown in Figure 1, A and B, DAB2IP-specific shRNA-
mediated suppression of endogenous DAB2IP significantly increased
radiation resistance in PC3 cells (Figure 1B). In contrast, the presence
of DAB2IP resulted in a significant radiation-sensitizing effect in C4-2
D2 cells (Figure 1A). Using colony formation assays, we found that
NU7441 significantly sensitized DAB2IP-negative (C4-2 neo and
PC3-KD) cells to IR. SF at 2 Gy (SF2) for C4-2 neo and PC3 KD cells
was reduced from 0.65 ± 0.023 and 0.86 ± 0.04 to 0.24 ± 0.04 and
0.55 ± 0.06, respectively. Here, we confirm, as previously shown
[5], that DAB2IP-expressing cells are more radiosensitive when com-
pared to DAB2IP-deficient cells. Furthermore, we found that NU7441
further sensitized DAB2IP-proficient cells to IR. SF2 values of C4-2
D2 and PC3 Con vector cells were decreased from 0.31 ± 0.06
and 0.58 ± 0.06 to 0.14 ± 0.02 and 0.02 ± 0.007, respectively. The
radiation-sensitizing effect of NU7441 is dose dependant (Figure 1C).
These in vitro results indicate that NU7441 can radiosensitize both
DAB2IP-positive and DAB2IP-negative PCa cells to radiation.
NU7441 Blocks IR-Induced DNA DSB Repair in
DAB2IP-Positive and DAB2IP-Negative PCa Cells
The extent of DNA DSBs generated and the ability of tumor cells to
repair the damage largely determine the efficacy of RT. Therefore, to
investigate whether the radiosensitizing effect of NU7441 on DAB2IP-
deficient cells was a result of compromised DSB repair, we subjected
cells to immunofluorescence staining for phosphorylated histone
H2AX (γH2AX) (green) and 53BP1 (red) (Figure 2, A and C ) and
determined DNA DSB repair kinetics by counting the separate foci
at each time point. In this study, C4-2 neo and D2 cells were exposed
to 2 μM NU7441 for 1 hour before 2-Gy IR treatment and the cells
were collected at various times as indicated. As shown in Figure 2C ,
rapid induction of DNA damage was detected within 30 minutes in
all of the cells. In untreated cells, DNA DSB foci were almost abolished
at 24 hours after IR, whereas a significant number of DSBs remained
at 24 hours in NU7441-treated cells; similar results were present in
PC3-KD cells (Figure 2, B and D). The residual number of DSB foci
per nucleus in DAB2IP-expressing C4-2 cells was significantly higher
than the control cells 30 minutes after IR; however, detectable foci fell
to the same level as control cells 24 hours after IR. This result indi-
cates that the presence of DAB2IP in C4-2 cells promotes IR-induced
DNA DSBs but has no effect on repair kinetics. Taken together, these
results show that NU7441 can lead to defective DNA damage repair in
response to IR even in DAB2IP-deficient metastatic PCa cells.
In mammalian cells, IR-induced cell cycle arrest is necessary to main-
tain genomic stability and is correlated to cell survival. In this study,
the effect of NU7441 on cell cycle distribution was investigated by
flow cytometry. As shown in Figure 3, A to D, treatment with 2 μM
NU7441 resulted in robust G2/M arrest 24 hours after irradiation
(2 Gy) in both DAB2IP-deficient or DAB2IP-expressing cell lines.
We further compared C4-2 neo and D2 cells and showed that the per-
centage of G0/G1 phase cells in C4-2 D2 was more than that in neo
(control) line. The cell cycle results indicate that DAB2IP alone causes
significant G0/G1 arrest in C4-2 cells and is augmented after treatment
with either IR or NU7441, whereas DAB2IP-deficient cells showed
moderate increase in G0/G1 arrest after NU7441 treatment. However,
both cell lines showed robust G2/M arrest at 24 hours in response to
combined treatment.
Figure 2. NU7441 blocks IR-induced DNA DSB repair in DAB2IP-positive and DAB2IP-negative PCa cells. PCa cells were treated with 2 μM
NU7441 for 30 minutes followed by IR (2 Gy); samples were collected at the indicated time points after IR, immune-stained for 53BP1
(red foci) and phospho-γH2AX (green foci), and counted (average, 50 nuclei). (A) C4-2 D2 and C4-2 neo cells. (B) PC3-KD cells. Quantitative
analysis of DNA repair kinetics between C4-2 cells (C) and PC3KD cells (D).
1206 DAB2IP Regulates Autophagy in PCa Radiotherapy Yu et al. Neoplasia Vol. 14, No. 12, 2012
DAB2IP Inhibits Irradiation-induced Autophagy
Autophagy is the mechanism of proteolysis and has been involved in
both cell survival and cell death [14]. In general, autophagy protects
cells from stressful conditions such as nutrient deprivation. There are
reports also indicating that autophagy protects cells from radiation [15].
To test whether DAB2IP is involved in PCa cell autophagy, first we
analyzed the formation of AVOs using AO staining with fluorescence
imaging and flow cytometry. During autophagy, AO accumulates in
acidic compartments such as autolysosomes. Using a laser scanning
confocal microscope, we found that the autophagic signal increases in
DAB2IP-deficient C4-2 neo cells after IR, NU7441, and the com-
bination of NU7441 and IR treatment. However, across the all three
treatment arms, there was a significant decrease in the amount of
autophagy in the DAB2IP-expressing cell line C4-2 D2 (Figure 4A).
To further confirm this result, we performed flow cytometric analy-
ses of AO-stained cells. As shown in Figure 4B, DAB2IP-deficient
cells display significantly more autophagy than DAB2IP-expressing
cells. We also performed the immunostaining with LC3B antibody
(Figure 4C ) and the results were consistent with Figure 4, A and B.
We further subjected C4-2 neo cells to IR combined with an auto-
phagy inhibitor, Bafliomycin A1 (Baf A1). The clonogenic assay clearly
showed that Baf A1 treatment enhanced radiation-induced cell death
in DAB2IP-deficient PCa cells (Figure 4D). On the basis of these
results, we propose that the decreased resistance to IR in DAB2IP-
expressing C4-2 cells may be partially due to the inhibition of autophagy.
DAB2IP Inhibits Autophagy through the
mTOR-S6K Pathway
To further explore the role of DAB2IP in autophagy, we deter-
mined the expression levels of the microtubule-associated protein
LC3B. LC3B exists in a cytosolic form, LC3B-I, and an LC3B-II
form that is conjugated to phosphatidylethanolamine [16,17]. In-
creased LC3B-II levels are closely associated with the number of auto-
phagosomes and serve as a good indicator of autophagosome formation
[18]. As shown in Figure 5, A and B, increased DAB2IP impairs
both IR- and NU7441-mediated induction of LC3B-II in C4-2 cells.
In addition, the lower expression of Beclin 1 protein was noticed in
DAB2IP-expressing C4-2 cells.
It is reported that Akt-mTOR pathway negatively regulates auto-
phagy [19]. To investigate how this signaling cascade is operated in
DAB2IP-associated autophagy inhibition in C4-2 cells, we measured
phosphorylation of mTOR in both cell lines (Figure 5). Compared
Figure 3. Cell cycle analysis in DAB2IP-negative and DAB2IP-positive PCa cells after treatment with NU7441 and IR. C4-2 D2 and C4-2
neo cells were treated with IR (2 Gy), NU7441 (2 μM), and IR + NU7441 as indicated. Samples were collected at 0, 2, 6, and 24 hours
post-treatment. Propidium iodide (PI) staining was used to detect the distribution of cells after various treatments. (A and B) C4-2 neo cells
and (C and D) C4-2D2 cells.
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Figure 4. DAB2IP expression suppressed IR- or NU7441 + IR–induced autophagy in PCa cells. C4-2 neo and D2 cells were treated with
NU744, IR, and IR + NU7441 for 72 hours and then stained with AO. (A) Fluorescent images of AVO-positive cells. (B) Flow cytometry
analysis to assess autophagy and (C) immunofluorescence staining of LC3B antibody. Experiments in A to C were performed under
identical conditions. (D) SF analysis of C4-2 neo cells after combined treatment of IR and an autophagy inhibitor Baf A1 as indicated.
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with C4-2 neo cells, there was a dramatic inhibition of phosphorylated
mTOR in C4-2 D2 cells. Furthermore, studies have shown that S6K
is a critical downstream effector of the mTOR signaling pathway
[20]. We observed decreased phosphorylation of S6K in DAB2IP-
overexpressed C4-2 D2 cells (Figure 5). Although mTOR-S6K ac-
tivation is known to suppress autophagy in mammalian cells, emerging
studies have indicated that, in certain situations, the mTOR-S6K
pathway positively regulates autophagy [21–23]. Together, our find-
ings show that DAB2IP may suppress IR- and NU7441-induced
autophagy through the mTOR-S6K pathway.
DAB2IP Promotes Apoptosis in Response to Combined
Treatment of NU7441 and IR
It is reported that autophagy is an adaptive mechanism that can
cause resistance to therapy-induced apoptosis [24]. In previous experi-
ments, we noticed that DAB2IP acts as an autophagy inhibitor and can
promote apoptosis in response to therapeutic agents. To explore, we
examine IR- and NU7441-induced apoptosis in C4-2 cells with or
without DAB2IP. Cells were fixed and stained with DAPI 12 hours
after NU7441 or/and IR treatment. As shown in Figure 6A, little or
no significant apoptotic event was noticed after IR or NU7441 treat-
ment alone, in either DAB2IP-negative or DAB2IP-positive cells.
However, C4-2D2 cells showed enhanced apoptosis (7.8%) after
combined treatment of IR + NU7441 after 12 hours, whereas C4-2
neo cells showed only 3.8% at the same time (Figure 6B; P < .05).
For further characterization, Western blot analysis was performed to
analyze cleaved PARP-1 (Figure 6C ). We noticed that the PARP-1
cleavage is greater (lane 8) in C4-2D2 cells when compared to neo
cells (lane 4) in response to IR + NU7441. These results suggest that
DAB2IP can promote cell death in PCa cells by blocking autophagy
when treated with IR + NU7441.
Loss of DAB2IP Correlates with Decreased BRFS
To determine whether loss of DAB2IP in PCa results in clinically
relevant radiation resistance, we performed a retrospective cohort
study of high-risk (PCa) patients treated with definitive RT (Fig-
ure 7). Patient’s DAB2IP status was determined using IHC and
patients were followed for biochemical recurrence as mentioned in
Materials and Methods section. Twenty-four patients treated for high-
risk PCa were evaluated. DAB2IP loss was seen in 8 patients (33.3%),
whereas 16 patients (66.7%) expressed DAB2IP. Median follow-up
for DAB2IP patients was 19.4 months (range, 8.2 to 57.8 months)
and 23.9 months (range, 8.8 to 74.0 months) for the DAB2IP-
deficient group. Patients expressing DAB2IP exhibited markedly
improved BRFS compared to patients with loss of DAB2IP (P = .027;
log-rank test). The estimated 2-year BRFS was 90% and 68.5%, re-
spectively, for the DAB2IP-present and DAB2IP-deficient groups.
At 4 years, BRFS was 90% and 34.3% for the present and deficient
groups, respectively. Univariate analysis demonstrated DAB2IP status
as the only variable with significant association to BRFS at this point
of follow-up.
Discussion
DAB2IP/AIP1, a potential tumor suppressor gene, is often down-
regulated in PCa primarily due to altered epigenetic regulation of its
promoter [25]. It functions as a key scaffold protein to modulate cell
proliferation, survival, and apoptosis by coordinating PI3K, Akt, and
the ASK1 pathway [26,27]. Our previous work indicated that loss of
DAB2IP expression in PCa cells greatly increases radiation resistance
in vitro [5,6]. To determine whether our previous in vitro findings
were clinically relevant, we performed a retrospective cohort study and
determined that loss of DAB2IP leads to significantly increased rates of
biochemical failure after RT (Figure 7).
Figure 5. DAB2IP inactivates mTOR-S6K pathway and suppresses the expression of autophagy-associated proteins. (A) The phosphoryla-
tion of mTOR and S6K and the expression of autophagy-associated Beclin 1 and LC3B were determined by Western blot analysis 24 hours
after IR (5 Gy). (B) The phosphorylation of mTOR and S6K and the expression of autophagy-associated Beclin 1 and LC3B were determined
by Western blot analysis at the indicated time points.
Neoplasia Vol. 14, No. 12, 2012 DAB2IP Regulates Autophagy in PCa Radiotherapy Yu et al. 1209
DNA-PKcs, a key component of the NHEJ pathway, plays a
dominant role in DNA DSB repair, genomic integrity, and main-
taining telomere stability [7,28] and is upregulated in various cancers
[29,30]. It is also reported that increased DNA-PKcs expression and
kinase activity are closely associated with radioresistance or chemo-
resistance [31,32]. Inhibitors of DNA-PKcs such as NU7441 have
been developed to enhance RT-based local tumor control [33]. In
this study, we clearly show that adjuvant treatment with NU7441
can overcome PCa radioresistance caused by loss of DAB2IP (Fig-
ure 1). NU7441-mediated radiosensitization in PCa cells is mainly
contributed to delayed IR-induced DSB repair. A recent study in
glioma-initiating cells demonstrated that DNA-PKcs is involved in
autophagy in response to irradiation. In these cells, suppression of
DNA-PKcs sensitizes cells to IR-induced autophagic cell death [11].
NU7441 is also known to inhibit PI3K-Akt [33], which is the
upstream of mTOR signaling pathway. Therefore, we have used
the inhibitors of PI3K (LY294002) and mTOR (rapamycin and
RAD001) pathways to test the radiosensitivity in DAB2IP-deficient
PCa (C4-2 neo) cells. In addition, we used a dual kinase inhibitor
NVP-BEZ235 that blocks both PI3K and mTOR signaling. Our
results showed that all three inhibitors exhibit radiation sensitivity
of C4-2 neo cells. The maximum radiosensitivity was achieved using
NVP-BEZ235, which indicates that both PI3K and mTOR pathways
were involved in the increased radioresistance of C4-2 neo cells (Fig-
ure W1, A and B). Furthermore, we used LY294002, an inhibitor of
the PI3K pathway in combination with radiation, which showed a
strong radiosensitizing effect in C4-2 neo cells (Figure W1A). We have
performed Western blot analyses to confirm that these inhibitors
blocked the PI3K (inhibition of pAKT) and mTOR (inhibition of
pS6K) signaling pathways (Figure W1, C and D).
Autophagy is a lysosomal degradation pathway that eliminates
damage or potentially dangerous proteins and organelles under adverse
conditions to protect organisms from metabolic stress [34]. Many
studies have shown that cancer cells use autophagy as an adaptive
and context-dependent system to overcome radiotherapeutic stress,
autophagy increases in tumor cells in response to radiation and DNA
damage, and radioresistance may be associated with autophagy induc-
tion [15,35–37]. On the basis of these evidences, autophagy-related
pathway has been considered as a potential and important therapeutic
target in radiation oncology. Therefore, we performed experiments to
determine whether the inhibition of DNA-PKcs can induce autophagy
in DAB2IP-deficient PCa cells and the precise role of this catabolic
process in radiation resistance. In this study, AVO staining was used to
compare cellular autophagy response to IR with or without NU7441
treatment. We noticed that NU7441 treatment can promote both
IR-induced and basal level of cell autophagy. The autophagy marker
protein LC3B is induced upon treatment with NU7441 (Figure 4).
In addition to DNA-PKcs, our expected results showed that DAB2IP
is also involved in autophagy pathway and overexpression of this gene
attenuated IR- and NU7441-induced autophagy. Furthermore, we
Figure 6. DAB2IP promotes apoptosis in response to IR + NU7441. (A) IR + NU7441–induced apoptosis was determined by DAPI staining.
Cells were treated with +/− NU7441 and IR (10 Gy) for 12 hours and the cells were stained with DAPI; the representative fluorescence
images are shown. White arrows indicated the mitotic cells and the red arrows represent the apoptotic cells. (B) Quantitative analysis of
apoptotic cells. The data are presented as the means ± SD of three independent experiments. (C) Analysis of PARP cleavage. Cells were
lysed 12 hours after exposure to IR or IR + NU7441 and subjected to Western blot analysis.
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observed that LC3B and Beclin 1 are downregulated in cells expressing
DAB2IP. These results suggest that DAB2IP mediated radiosensitiza-
tion of PCa cells partially through inhibition of autophagy. To further
prove this, we treated PCa cells with autophagy inhibitor Baf A1 after
irradiation. We found that Baf A1 significantly enhanced radiation sen-
sitivity (Figure 4D). The mTOR-S6K pathway is postulated to be a
negative regulator of mammalian autophagy [19]. In contrast, we show
that mTOR-S6K pathway was inactivated in DAB2IP-expressing PCa
cells. Studies show that mTOR can also positively modulate autophagy.
Klionsky et al. reported that mTOR inhibition by rapamycin or siRNA-
mediated silencing of S6K expression reduced 6-thioguanine–induced
autophagy in human colorectal cancer cells [23]. Scott et al. suggested
that S6K is essential for autophagy in fat cells of Drosophila [22]. Con-
sistent with these reports, our results showed that phosphorylation of
S6K was almost totally attenuated in DAB2IP-expressing PCa cells.
Notably, DAB2IP functions as a scaffold protein to inhibit the PI3K-
Akt pathway using a direct protein interaction with PI3K through its
PR domain [26].
Autophagy-defective cells also show an increase in DNA-DSB in
response to various stresses, including IR [13,38]. To further evaluate
the role of autophagy in DNA-DSB repair, we found that DAB2IP-
proficient PCa cells exhibit higher level of DNA damage compared
to control cells after IR treatment. We believe that the inhibition of
autophagy in DAB2IP-proficient cells is the major contributing factor
toward the impaired DNA damage. Moreover, recent work indicates
that autophagy can promote tumor cell survival and inhibition of
autophagy leads to significant tumor regression [39]. It is conceivable
that DAB2IP inhibits autophagy that could contribute to the sup-
pression of tumor growth and aggressiveness.
In summary, the results of this study demonstrate that inhibition of
DNA-PKcs enhances the effect of IR in DAB2IP-deficient radioresis-
tant human PCa cells. Moreover, our findings demonstrate a role for
DAB2IP in inhibiting mTOR-S6K pathway and suppressing auto-
phagy. On the basis of these results, DAB2IP appears to be an excellent
RT target in the treatment of PCa.
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Supplementary Methods
Clonogenic Survival Assay
Exponentially growing cells were trypsinized and counted using
a Coulter counter (Beckman Coulter). Cells were diluted serially to
appropriate concentrations and plated onto 60-mm dishes in triplicates.
After 3 hours of incubation, cells were treatedwith increasing doses of IR
(2, 4, 6, and 8 Gy) or indicated drugs (25 nM NVP-BEZ235, 10 μM
LY294002, 100 nM rapamycin, or 10 nM RAD001) or drugs + IR.
For NVP-BEZ235 treatment, drug-containing medium was replaced
with drug-free medium at 16 hours after IR. After 10 to 14 days,
cells were fixed and stained with 4% formaldehyde and 0.05%
crystal violet in PBS. Colonies containing >50 cells were counted.
SF was calculated as (mean colony counts)/[(cells inoculated) ×
(plating efficiency)], in which plating efficiency was defined as
(mean colony counts)/(cells inoculated for unirradiated controls).
The data are presented as means ± SD of at least three independent
experiments. The curve S = e−(αD + βD2) was fitted to the experimen-
tal data using a least-squares fit algorithm using the program Sigma
Plot 11.0 (Systat Software, Inc).
Western Blot Analysis
C4-2 neo cells were treated with LY294002 (10 μM), NVP-
BEZ235 (25 nM), rapamycin (100 nM), and RAD001 (10 nM) as
indicated for 1 hour, followed by radiation (10 Gy). After 1 hour, cells
were lysed and Western blot analysis was performed.
 
Figure W1. PI3K-AKT and PI3K-mTOR inhibitors increase the radiosensitivity in DAB2IP-negative PCa cell line. (A) The SF analysis of C4-2
neo cells after combined treatment with 10 μM LY294002 and IR or 25 nM NVP-BEZ235 and IR. (B) SF analysis of C4-2 neo cells after
combined treatment with 100 nM rapamycin and IR or 10 nM RAD001. (C) C4-2 neo cells were irradiated (10 Gy) after 1 hour of
10 μM LY294002 or 25 nM NVP-BEZ235 treatment and harvested at 1 hour after IR. Inhibition of PI3K-Akt pathway was analyzed by
Western blot analysis with phospho-Akt (Ser473) antibody. (D) C4-2 neo cells were irradiated (10 Gy) after 1 hour of 100 nM rapamycin
or 10 nM RAD001 treatment and harvested at 1 hour after IR. Inhibition of mTOR pathway was analyzed by Western blot analysis with
phospho-S6K antibody.
